Background: Abnormal lipid metabolism is one of many factors that contribute to the development of ulcerative colitis (UC). As a lipid droplet-associated
acids, is significantly associated with higher risk of UC. 8 In contrast, dietary n-3 fatty acids play a protective role by reducing oxidative stress and modifying the gut microbiota and inflammatory pathways. [9] [10] [11] [12] The colon absorbs more than 95% of shortchain fatty acids ingested, 13 and impaired short-chain fatty acid metabolism in the colon has been suggested as a pathogenic factor in UC. 14 Therefore, defects in intestinal lipid metabolism could lead to diseases such as celiac disease and malnutrition, but its association with the development of UC are still controversial. 9, 15 In mammalian cells, excessive intracellular fatty acids are esterified and stored in lipid droplets (LDs) in form of triglycerides (TGs) to avoid lipotoxicity. LDs are highly dynamic cellular organelles 16 and are regulated by LD-associated proteins (LDPs).
As an LDP, cell death-inducing DFF45-like effector b (Cideb) is abundantly expressed in the intestinal mucosa and plays crucial roles in maintaining intestinal lipid homeostasis by promoting the lipidation and maturation of chylomicron particles. 17, 18 Cideb deficiency impeded the export of lipids from enterocytes and intestinal lipid absorption, which led to excessive lipid accumulation in the intestinal mucosa 18 ; however, its roles in intestinal diseases are still unknown.
In this study, we found that the levels of Cideb were upregulated in the colonic mucosa of patients with UC, and dextran sodium sulfate (DSS) treatment coincidently increased the expression of Cideb in the colonic mucosa. Thus, DSS-induced colitis model in Cideb-null mice was used to investigate the functional roles of Cideb in the development of UC, which could offer insight into the pathogenesis of and therapeutic avenues for UC.
MATERIALS AND METHODS

Animals and Tissue Collection
Cideb-null mice were produced as previously reported 17 and were generously donated by Prof. Peng Li at Tsinghua University. The experimental protocols were approved by the animal ethical committee of the Fourth Military Medical University. UC and normal control colon tissue specimens were obtained from the Department of Pathology, Xijing Hospital, the Fourth Military Medical University. The patients' demographic and clinical information is summarized in Table 1 , Supplemental Digital Content 1, http://links.lww.com/IBD/B558.
Immunohistochemical and TUNEL Staining
The procedures for immunohistochemical (IHC) staining have been described previously. 19 Briefly, primary anti-Cideb antibody (1:200), 18 anti-F4/80 antibody (1:200, Abcam, Cambridge, United Kingdom), and anti-MUC2 antibody (1;300, Genetex) were applied to 3-mm slides and incubated overnight at 48C. For detection, the samples were treated with the Dako Envision Flex amplification kit for 30 minutes, and the peroxidase activity was revealed using a 3,3 0 -diaminobenzidine tetrahydrochloride (DAB) solution containing 0.03% hydrogen peroxide. After the slides were counterstained with hematoxylin and mounted, the slides were examined and photographed. The immunoreactivity of cytosolic Cideb in the colonic mucosa was scored according to intensity (0 ¼ negative, 1 ¼ weak, 2 ¼ moderate, and 3 ¼ strong staining). Apoptotic cells were identified using a one-step TUNEL assay kit (Beyotime Institute of Biotechnology, Jiangsu, China) according to the manufacturer's instructions. The sections were mounted on glass slides, deparaffinized, and stained with the TUNEL reaction mixture for 1 hour at 378C in the dark. Then, the sections were washed with phosphate-buffered saline (PBS) and counterstained with Hoechst (Sigma-Aldrich, St. Louis, MO), and the positive cells were counted under a fluorescence microscope.
Induction of Colitis
Mice (4 weeks old) were fed either a normal diet (ND, 30 kcal% protein, 60 kcal% carbohydrate, 10 kcal% fat diet) or high-fat diet (HFD, 20 kcal% protein, 20 kcal% carbohydrate, 60 kcal% fat diet, from Xietong Biotech, Jiangsu, China) for 6 days followed by untreated water for another 2 days, after which the mice were killed. The entire colon was immediately isolated, and its length was measured. The disease activity index (DAI) was determined using a modified scoring system as previously described. 20, 21 Briefly, the following parameters were determined: body weight loss relative to day 0 (0: ,1%, 1: 1%-5%, 2: 5%-10%, 3: 10%-15%, 4: .15%), stool consistency (0: normal, 2: loose, 4: diarrhea), and presence of fecal blood (0: negative, 1: weak positive, 2: moderate positive, 3: strong positive, 4: gross bleeding). Evaluation of DAIs was performed in a blinded fashion, and the total DAI score (ranging from 0 to 12) was calculated by summing up the individual scores.
Histological Analysis
For histological analysis, colon segments from the control and DSS-treated mice were fixed in 10% formalin in PBS and then embedded in a paraffin block. Sections (3-mm thickness) were stained with hematoxylin/eosin, and the histological scoring was graded by 2 blinded pathologists based on a modified scoring system 22 that included the following: degree of inflammation (0, none; 1, slight; 2, moderate; 3, severe), depth of inflammation (0, none; 1, only mucosa; 2, submucosa; 3, transmural), severity of crypt damage (0, none; 1, basal 1/3; 2, basal 2/3; 3, only surface epithelium intact; 4, entire crypt and epithelium lost), and percentage of mucosa involved (0, none; 1, 1%-25%; 2, 26%-50%; 3, 51%-75%; 4, .75%). The total histological score (ranging from 0 to 14) was calculated by summing up the individual scores.
Immunoblotting Analysis
The colonic mucosa was harvested by blunt light scraping and lysed in radio-immunoprecipitation assay buffer, and the protein concentrations in the soluble lysates were determined by the Bradford method (Bio-Rad, Hercules, CA). Immunoblotting was performed as previously described. 23 Briefly, proteins (10-50 mg/lane) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto a polyvinylidene fluoride membrane. After the membrane was blocked with 0.5% nonfat milk, they were incubated overnight at 48C with anti-NF-kB p65 (Abcam) and anti-IkBa (Abcam) antibodies. The membrane was washed with 1X phosphate buffered saline tween-20 and incubated with horseradish peroxidase-conjugated secondary antibody for 45 minutes. The proteins of interest were detected using enhanced chemiluminescence, and b-tubulin was used as a loading control.
Quantitative PCR
Total RNA from excised colons was isolated using TRIzol reagent according to the manufacturer's instructions. The purity and integrity of extracted RNA was evaluated using spectrophotometer (NanoDrop 2000; Thermo Fisher Scientific, Waltham, MA) and electrophoresis, and the extracted RNA with a ratio of 260 to 280 nm about 2.0 and a ratio of 28S and 18S ribosomal RNA bands about 2.0 was used. The complementary DNA was produced by using an RNA reverse transcription kit (Takara, Japan), and the messenger RNA levels of Cideb, tumor necrosis factor-alpha (TNF-a), interleukin-1 beta (IL-1b), and interleukin-6 (IL-6) were analyzed by quantitative PCR with b-actin as an internal control. The primer sequences are listed in Table 2 , Supplemental Digital Content 2, http://links.lww.com/IBD/B559. Real-time PCR was performed using the ABI PRISM 7500 system (Applied Biosystems, Foster City, CA) and the SYBR Green kit.
Cytokine Determination and Myeloperoxidase Analysis
Before euthanization, mice were deeply anaesthetized, and the blood was collected by cardiac puncture. The serum was isolated, frozen, and stored at 2808C. The levels of IL-1b, IL-6, and TNF-a in the serum and colonic extracts were determined by specific enzyme-linked immuno sorbent assay (ELISA) kits according to the manufacturer's instructions (eBioscience, San Diego, CA). Myeloperoxidase activities in the colonic tissues were analyzed by commercial detection kits (Jiancheng, China).
Lipid Analysis
For Oil Red O staining, 10-mm frozen sections of colonic tissues were fixed in 4% polyformaldehyde, stained with Oil Red O, and counterstained with hematoxylin as previously described. 18 For triglyceride (TG) quantification, fecal pellets were collected from day 3 to day 5 after DSS treatment and stored at 2208C. The lipids were extracted from the dried feces and colonic mucosa using hexane/isopropanol (3:2, v/v) solvents. The organic phases were evaporated under a nitrogen stream at 608C and dissolved in PBS containing 2% Triton X-100. The levels of TG, free fatty acids, and total cholesterol in the colonic mucosa were analyzed using standard enzymatic kits (Wako Diagnostics, Japan) as previously described. 18 
Determination of Oxidative Stress
The colons from control and DSS-treated mice were homogenized with PBS and then centrifuged at 12,000 g for 20 minutes. The levels of glutathione (GSH), malondialdehyde (MDA), and reactive oxygen species (ROS) as well as the activity of superoxide dismutase (SOD) were detected by using commercial kits (Jiancheng, China) according to manufacturer's instructions as previously described. 23 
Cell Culture and Adenovirus Infection
Caco-2 cells were cultured in Dulbecco's modified eagle medium (DMEM) supplemented with 10% fetal bovine serum and differentiated as previously reported. 18 Cells were infected with adenoviruses containing human Cideb to generate Cidebexpressing Caco-2 cells, and the adenovirus containing green fluorescent protein (GFP) was used as a negative control. All experiments were conducted 4 to 5 days after adenovirus infection. The cells were treated with 100 mM oleic acid (OA) for 12 and 24 hours, and 4 mM OA in 10% bovine serum albumin was used as the stock solution. The TG and ROS levels as well as SOD activity were determined as previously described, and the expression levels of Cideb, NF-kB, and IKBa were detected by immunoblotting.
Statistical Analysis
All results are presented as the mean 6 SEM, and the data were analyzed by using the 2-sided Student's t test with Prism 5.0 software (GraphPad Prism). Differences of P , 0.05 were considered to be statistically significant. *P , 0.05, **P , 0.01, ***P , 0.001 versus control group.
RESULTS
Cideb Expression Was Elevated in the Colonic Mucosa of Patients with Ulcerative Colitis
Cideb is an LDP and is abundantly expressed in the intestinal mucosa. 17, 18 Therefore, we analyzed the expression of Cideb in the colonic mucosa of patients with moderate and severe UC, and the IHC staining indicated that the expression of Cideb was higher in the colonic mucosa of patients with UC than that in control normal mucosa (Fig. 1A, B) , and Cideb was mainly expressed in the glycocalyx layer of mucosa. Intriguingly, IHC staining also showed that the expression of Cideb in the colonic mucosa was increased in the mice treated with DSS, which has been shown to experimentally induce UC (Fig. 1C) . Consistently, the results of the immunoblot and quantitative PCR indicated that both the protein and messenger RNA levels of Cideb in the colonic FIGURE 2. Cideb deficiency aggravated the symptoms of DSS-induced colitis. A and B, DSS-induced weight loss was more severe in Cideb-null (2/2) mice compared with that in wild-type (+/+) mice on ND consumption (A) and was more significant in mice fed an HFD (B). C, The DAI in mice treated with DSS was elevated in Cideb-null (2/2) mice compared with wild-type (+/+) mice, and HFD consumption exacerbated the increase of DAI. Values represent the mean 6 SEM (n ¼ 5). *P , 0.05, **P , 0.01 and ***P , 0.001 versus wild-type (+/+) group. mucosa were upregulated in DSS-treated mice (Fig. 1D, E) . Therefore, the functional roles of elevated Cideb in the colonic mucosa of UC should be further investigated.
Cideb Deficiency Aggravated DSS-induced Colitis in Mice
The wild-type and Cideb-null mice were administered 3% DSS for 6 days and switched to normal water for 2 days to induce experimental colitis. An HFD was also introduced to increase the intestinal burden of lipid disposal. The DSS water intakes were similar in the wild-type and Cideb-null mice fed with ND or HFD (see Fig. 1A and B, Supplemental Digital Content 3, http://links. lww.com/IBD/B560). The results indicated that in mice fed an ND, DSS-induced weight loss was aggravated in Cideb-null mice compared with that in wild-type mice (Fig. 2A) ; furthermore, the weight loss was more severe when the mice were fed an HFD (Fig. 2B) . Moreover, the DAI indicated that the symptoms of DSS-induced colitis were aggravated in Cideb-null mice compared with those in wild-type mice, and HFD consumption exacerbated the symptomatic deterioration of DSS-induced colitis in Cideb-null mice (Fig. 2C) .
Animals were killed 2 days after stopping DSS administration, and the colon was rapidly removed to analyze the length and histological changes. The results showed that in mice fed an ND, the colon length of Cideb-null mice was significantly shortened by DSS treatment compared with that of wild-type mice (Fig. 3A) , whereas HFD consumption made the colonic shortening more severe in Cideb-null mice (Fig. 3B) . Consistently, the microscopic evaluation of colon sections stained with haematoxylin/eosin showed that severe microscopic damage, including loss of mucosal architecture, smooth muscle thickening, presence of crypt abscesses, and extensive lymphoplasmacytic infiltration, was observed in DSS-treated colon specimens (Fig. 3C) . The histological scores of the colon specimens indicated that more severe DSS-induced damage was observed in Cideb-null mice compared with that in wild-type mice, and HFD consumption exacerbated the DSS-induced histological damages in Cideb-null mice (Fig. 3D) . Moreover, TUNEL staining indicated that the levels of apoptosis in DSS-treated colonic mucosa were elevated in Cideb-null mice compared with those in wild-type mice, and a more significant elevation of TUNEL-positive cells was found in the DSS-treated Cideb-null mice fed an HFD (Fig. 3E) . Thus, Cideb deficiency aggravated DSS-induced colitis in mice, and HFD consumption led to more significant deterioration.
Cideb Deficiency Increased the DSS-induced Inflammation in Mice
DSS-induced colitis is also related to various proinflammatory mediators, which have been associated with the pathogenesis of human UC. The ELISA results showed that DSS treatment FIGURE 3. Cideb deficiency aggravated the colonic shortening and histological damage in DSS-induced colitis. A and B, The colons of Cideb-null (2/2) mice were shorter than those in wild-type (+/+) mice after DSS treatment under ND condition (A), and the DSS-induced colonic shortening was more severe in HFD-fed mice (B). C and D, Representative micrographs (C) and histological scores (D) of colonic tissue sections indicated that the DSS-induced histological damage was more severe in Cideb-null (2/2) mice than that in wild-type (+/+) mice, and HFD consumption exacerbated the histological damage due to Cideb deficiency. E, Representative micrographs of TUNEL staining showed that the number of apoptotic cells was increased in the DSS-treated colonic mucosa of Cideb-null (2/2) mice compared with that of wild-type (+/+) mice under both ND and HFD conditions. Values represent the mean 6 SEM (n ¼ 5). *P , 0.05 and **P , 0.01 versus wild-type (+/+) group. Scale bar, 200 mm.
significantly elevated the serum levels of proinflammatory cytokines in mice, including IL-1b (Fig. 4A ), IL-6 (Fig. 4B) , and TNF-a (Fig. 4C) . More importantly, the levels of serum IL-1b, IL-6, and TNF-a were coincidently higher in Cideb-null mice than those in wild-type mice treated with DSS, and HFD consumption led to a more significant elevation of these inflammatory cytokines in Cideb-null mice (Fig. 4A-C) . In addition to the proinflammatory mediators in serum, the levels of IL-1b, IL-6, and TNF-a in colonic tissues were also elevated in Cideb-null mice compared with those in wild-type mice treated with DSS, and more significant increases were found in Cideb-null mice fed an HFD (Fig. 4D-F) , which were consistent with the messenger RNA levels (see Fig. 2 , Supplemental Digital Content 4, http://links.lww.com/IBD/B561). Furthermore, the activity of colonic myeloperoxidase was also higher in Cideb-null mice than in wild-type mice after treatment with DSS, and the elevation of colonic myeloperoxidase activity in Cideb-null mice became more significant when the mice consumed an HFD (Fig. 4G) . IHC staining indicated that the number of F4/80-positive cells was greater in DSS-treated colons from Cideb-null mice than those in wild-type mice and was significantly elevated on HFD consumption (Fig. 4H) . Collectively, Cideb deficiency increased DSS-induced inflammation in mice, and HFD consumption led to more significant elevation of inflammatory responses in Cideb-null mice.
Cideb Deficiency Aggravated Colonic Oxidative Stress in DSS-treated Mice
In addition to the proinflammatory cytokines, we further investigated oxidative stress in DSS-induced colitis in Cideb-null and wild-type mice, including the colonic levels of MDA, ROS, and glutathione (GSH), as well as the activity of SOD. The results , and TNF-a (C and F) after DSS treatment were higher in Cideb-null (2/2) mice than in wild-type (+/+) mice, and HFD consumption exacerbated the elevation of these inflammatory cytokines in Cideb-null mice. G, The colonic myeloperoxidase activity after DSS treatment was elevated in Cideb-null (2/2) mice compared with that in wild-type (+/+) mice and was more significant in mice consuming an HFD. H, IHC staining showed that the number of infiltrative F4/80-positive cells was increased in the DSS-treated colonic mucosa of Cideb-null (2/2) mice compared with that of wild-type (+/+) mice under both ND and HFD conditions. Values represent the mean 6 SEM (n ¼ 5). *P , 0.05, **P , 0.01 versus wild-type mice. Scale bar, 50 mm.
revealed that HFD consumption led to a significant elevation of the colonic MDA and ROS levels in Cideb-null mice compared with those in wild-type mice with DSS treatment (Fig. 5A, B) . In contrast, the colonic levels of GSH and the activity of SOD were lower in Cideb-null mice than those in wild-type mice with DSS treatment when consuming an HFD (Fig. 5C, D) . Thus, Cideb deficiency aggravated colonic oxidative stress in DSS-treated mice under HFD condition.
Cideb Deficiency Increased the Lipid Content in the Feces and Colonic Mucosa of DSStreated Mice
Cideb deficiency led to excess lipid accumulation in intestinal mucosa and impaired lipid absorption 18 ; thus, we further analyzed the lipid contents in the fecal pellets of DSS-treated mice. The results showed that the fecal cholesterol levels were similar in Cideb-null and wild-type mice either with or without DSS treatment (Fig. 6A) . However, the fecal levels of TGs and free fatty acids were higher in Cideb-null mice than those in wildtype mice treated with DSS and fed an HFD (Fig. 6B, C) . Oil Red O staining revealed that in mice fed an HFD, more lipid content was found in the DSS-treated colonic mucosa of Cideb-null mice compared with that of wild-type mice (Fig. 6D) . Consistently, the quantification of these data showed that on HFD consumption, the TG content was higher in the DSS-treated colonic mucosa of Cideb-null mice than that of wild-type mice (Fig. 6E) . Excess lipid accumulation, especially free fatty acid, could activate oxidative stress, which is usually mediated by upregulated NF-kB signaling. 24 Here, immunoblotting revealed that the colonic NF-kB levels were increased, but the IkBa levels were decreased in Cideb-null mice with DSS treatment, especially on HFD consumption (Fig. 6F) . Collectively, Cideb deficiency increased the lipid contents in the feces and colonic mucosa of DSS-treated mice.
Cideb Reduced the Lipid Accumulation and Oxidative Stress in Caco-2 Cells
Differentiated polarized Caco-2 cells (a human colon carcinoma cell line) have been shown to acquire many features of enterocytes. Because of the reduced expression of Cideb in differentiated Caco-2 cells, we overexpressed Cideb in Caco-2 cells to verify its roles in the lipid metabolism and oxidative stress response of enterocytes. After the Caco-2 cells were polarized in a transwell system and infected with either Cideb-or GFPexpressing adenovirus, they were cultured in DMEM containing 100 mM OA for 12 and 24 hours. Immunoblotting showed that the levels of NF-kB were reduced, and that the IkBa levels were elevated in Cideb-expressing Caco-2 cells treated with OA for 12 and 24 hours (Fig. 7A) . Moreover, the levels of TG, MDA, and ROS were decreased in OA-induced Caco-2 cells after overexpression of Cideb (Fig. 7B-D) . Furthermore, in the presence of OA, the SOD activity was also elevated in Cidebexpressing Caco-2 cells compared with the control cells expressing GFP (Fig. 7E) . The in vitro evidence proved that Cideb expression in polarized Caco-2 cells in the presence of OA could reduce TG accumulation and oxidative stress.
DISCUSSION
Inflammatory bowel diseases, including UC and Crohn's disease, are predominantly characterized by recurrent inflammation of the intestine, yet genetic alterations only account for approximately one-fifth of disease development. 25 An HFD may contribute to the alterations of intestinal inflammation, intestinal permeability, and host microbiota, 7 and the westernized diet, which is enriched with fats, could either induce the development of UC 7 or increase the likelihood of relapse for colitis patients. 5, 6 In addition, the high-fat intake also results in obesity, a condition that is constantly associated with low-grade inflammation, which may explain why an HFD can accelerate the development of DSSinduced colitis. However, the association between defects of intestinal lipid metabolism and the development of UC is still controversial. 9, 15 In mammalian cells, excess fatty acids are esterified into TG and stored in LDs, which play crucial roles in regulating lipid metabolism in the cell. The homeostasis of intracellular LDs is controlled by LDPs. The members of the cell death-inducing DFF45 such as effector (CIDE) family have been proven to be important LDPs and comprise Cidea, Cideb, and Fsp27 (Cidec in humans). 26, 27 Our previous study revealed that Cideb is an LDP that localizes to the surface of LDs and the endoplasmic reticulum. Cideb interacts with ApoB and promotes the lipidation and maturation of very-low-density lipoproteins in the liver. 17 Cideb is also abundantly expressed in the intestinal epithelium as well, but its roles in the intestinal disease are still ill-defined. We also revealed that Cideb played crucial roles in the lipidation and maturation of chylomicrons in enterocytes 18 ; furthermore, Cideb deficiency impeded the export of lipids from enterocytes and led to excessive lipid accumulation in the intestinal mucosa. 18 In this study, we found that the expression of Cideb in the colonic mucosa of patients with UC was elevated and was coincidently increased in a mouse model of DSS-induced colitis, and Cideb deficiency aggravated the DSS-induced colitis, with more severe symptoms manifesting on HFD consumption. The evidences proved that Cideb expression reduced the TG accumulation and oxidative stress in both colonic epithelium and OA-treated Caco-2 cells. However, MUC2, a major component of the mucus gel, was unchanged in the colonic mucosa of DSStreated Cideb-null mice compared with that of wild-type mice under either ND or HFD conditions (see Fig, Supplemental   FIGURE 6 . Cideb deficiency increased the lipid content in the feces and colonic mucosa of DSS-treated mice. A, No difference in fecal cholesterol levels was found between the wild-type (+/+) and Cideb-null (2/2) mice fed either an ND or HFD. B and C, The fecal levels of TG (B) and free fatty acid (C) in mice fed an ND and treated with DSS were elevated in Cideb-null (2/2) mice compared with wild-type (+/+) mice, and HFD consumption exacerbated this elevation in Cideb-null mice. D and E, Oil Red O staining (D) and TG quantification (E) indicated that the lipid contents and TG levels in mice fed an HFD were higher in the DSS-treated colonic mucosa of Cideb-null (2/2) mice compared with that of wild-type (+/+) mice. F, Immunoblotting showed that in the DSS-treated colonic mucosa of Cideb-null (2/2) mice, NF-kB was upregulated, but IkBa was downregulated regardless of diet. Values represent the mean 6 SEM (n ¼ 5). *P , 0.05, **P , 0.01 versus wild-type mice, and ##P , 0.01, ###P , 0.01 versus ND-fed mice. Scale bar, 50 mm.
Digital Content 5, http://links.lww.com/IBD/B562), which indicated that Cideb deficiency might not affect the integrity of mucosal barrier. Collectively, our present data suggested that Cideb plays crucial protective roles in the development of UC by reducing lipid accumulation in the colonic mucosa.
As an LDP, Cideb promotes the lipidation and maturation of hepatic very-low-density lipoprotein particles and intestinal chylomicrons by interacting with ApoB, and Cideb deficiency could lead to the defects in lipid exports from hepatocytes and enterocytes. 17, 18 In Cideb-null mice, excess lipid accumulation in colonocytes contributed to the development of DSS-induced colitis, and 2 potential mechanisms might be involved. The first relates to lipid absorption defects in the small intestines of Cideb-null mice, which led to excess lipids in the colonic epithelium. The second is that Cideb deficiency could directly reduce the export of lipids from colonocytes, although the expression of Cideb in the colon is relatively lower compared with that in the jejunum. 17, 18 The excess lipid accumulation in the colonic epithelium of Cideb-null mice enhanced the oxidative stress by increasing the fatty acid oxidation, which might be the main cause of the severe UC development in Cideb-null mice. Thus, the elevated expression of Cideb in the colonic mucosa of patients with UC and DSS-induced colitis might play a protective role.
Briefly, our data suggest that Cideb protects against the development of UC by reducing the lipid accumulation and oxidative damage in colonocytes. These results are crucial for understanding the role of intestinal lipid metabolism defects in the pathogenesis of UC and indicate that Cideb could serve as a potent therapeutic target for UC.
